Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Crypto

Bitwise Files for Dogecoin ETF as Musk’s D.O.G.E Initiative Boosts Memecoin

by Team Lumida
January 23, 2025
in Crypto
Reading Time: 3 mins read
A A
0
gold and silver round coin

Photo by Kanchanara on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com
• Bitwise officially files for Dogecoin ETF following similar moves by Rex Shares and Osprey Funds
• DOGE market cap reaches $52 billion, tripling in value over past year
• Musk’s Department of Government Efficiency (D.O.G.E) creates unexpected catalyst
• Bitcoin ETFs have attracted over $50 billion in past year, setting precedent

What Happened?

Bitwise has officially filed registration for a Dogecoin ETF with Delaware’s Department of State’s Division of Corporations. This move follows similar filings by Rex Shares and Osprey Funds, indicating growing institutional interest in the world’s largest memecoin. The timing coincides with the launch of Elon Musk’s Department of Government Efficiency (D.O.G.E), creating an unexpected connection that has fueled market speculation.

Why It Matters?

This development represents a potential watershed moment for cryptocurrency markets, particularly in the memecoin sector. A SEC-approved Dogecoin ETF would provide institutional validation and create easier access for traditional investors. The coincidental connection to Musk’s D.O.G.E initiative has added a unique governmental angle to the token’s value proposition. With Bitcoin ETFs already attracting over $50 billion in investments, even a fraction of similar interest could significantly impact DOGE’s market dynamics.

What’s Next?

Market attention will focus on the SEC’s response to these ETF applications, particularly given the recent approval of Bitcoin ETFs. Traders will closely monitor the relationship between D.O.G.E’s governmental initiatives and DOGE’s price movements. The success of Bitcoin ETFs could provide a blueprint for potential inflows if approved. Key metrics to watch include institutional adoption rates, regulatory developments, and any further connections between the memecoin and Musk’s government efficiency program. The outcome could set precedents for other alternative cryptocurrency ETFs and influence the broader digital asset market structure.

Source
Previous Post

Gold Nears Record High as Trump’s Tariff Threats Spark Safe-Haven Demand

Next Post

LA Wildfire Survivors Face Complex Challenges Despite Intact Homes

Recommended For You

Binance’s Iran Exposure Resurfaces: Internal Probe Halted After Zhao Pardon, Staff Ousted, WSJ Reports

by Team Lumida
1 day ago
Binance’s Iran Exposure Resurfaces: Internal Probe Halted After Zhao Pardon, Staff Ousted, WSJ Reports

Key takeaways Powered by lumidawealth.com WSJ reports Binance investigators traced $1B+ in flows (primarily tether) from a key partner-linked account to an Iran-linked network, then were suspended/fired after escalating...

Read more

Bitcoin Slips Below $65K as Tariff Whiplash Rekindles Macro Risk-Off

by Team Lumida
2 days ago
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Key takeaways Powered by lumidawealth.com Bitcoin briefly fell below $65,000 (down ~4.8% intraday) as tariff uncertainty hit risk assets; Ether dropped more (~5%+). Market focus is shifting to $60,000...

Read more

Bitcoin Stuck in Narrow Range as Crypto Hedge Funds Shift to Cash and Cut Risk

by Team Lumida
5 days ago
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Key takeaways Powered by lumidawealth.com Bitcoin has settled into a narrow range of $67,000, showing little directional conviction after a significant drop from its October peak of $127,000. A...

Read more

Trump Family Crypto Platform Pulls In Wall Street and Regulators as “TradFi” Warms to Digital Assets

by Team Lumida
6 days ago
Fed Official Warns of Inflation Risks Under Trump Presidency

Key takeaways Powered by lumidawealth.com World Liberty Financial, tied to the Trump family, convened senior Wall Street leaders and regulators—signaling crypto’s elevation as a policy priority in Trump’s second...

Read more

Peter Thiel Fully Exits ETHZilla as Ether Treasury Model Comes Under Pressure

by Team Lumida
7 days ago
Peter Thiel Fully Exits ETHZilla as Ether Treasury Model Comes Under Pressure

Key Takeaways Powered by lumidawealth.com Peter Thiel and Founders Fund sold their entire position in ETHZilla, exiting a stake that was previously disclosed at 7.5%. ETHZilla is part of...

Read more

Bitcoin Wobbles After Fourth Straight Weekly Loss as ETF Outflows Keep Risk Appetite Fragile

by Team Lumida
1 week ago
Bitcoin Mining Stocks Outperform BTC in Early 2025, Network Strength Grows

Key Takeaways Powered by lumidawealth.com Bitcoin posted its fourth consecutive weekly loss and failed to hold a weekend bounce toward ~$71,000, signaling weak follow-through. The token is down >40%...

Read more

Coinbase Jumps ~20% After Earnings Miss as Bitcoin Bounce Sparks “Bottom-Fishing” Rally

by Team Lumida
1 week ago
Coinbase Q2 2024 Earnings Highlights: Diversification Drives Sixth Consecutive Quarter of Positive Adjusted EBITDA

Key Takeaways: Powered by lumidawealth.com Coinbase shares rose ~17%–20% on more than double-average volume, even after a weak quarter, suggesting expectations were already very low. Bitcoin rebounded as much...

Read more

Coinbase Swings to $667M Loss as Crypto Slowdown Tests Diversification Strategy

by Team Lumida
2 weeks ago
Coinbase Swings to $667M Loss as Crypto Slowdown Tests Diversification Strategy

Key Takeaways: Powered by lumidawealth.com Coinbase posted a $667 million net loss as revenue fell 20% to $1.8 billion amid declining crypto prices and trading activity. Bitcoin’s nearly 50%...

Read more

Strategy Turns to 11% Preferred Stock as Bitcoin Slide Pressures Equity Model

by Team Lumida
2 weeks ago
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Key Takeaways: Powered by lumidawealth.com Strategy will issue more perpetual preferred shares (“Stretch”) with an 11.25% variable dividend to attract investors wary of stock volatility. The firm holds over...

Read more

Bitcoin Whales Step In As Market Rebounds, but Doubts Persist

by Team Lumida
2 weeks ago
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Key Takeaways: Large Bitcoin holders, or "whales," have added 53,000 coins in the past week, stabilizing prices after a significant drop. Despite this, the broader market remains cautious,...

Read more
Next Post
silhouette of trees on smoke covered forest

LA Wildfire Survivors Face Complex Challenges Despite Intact Homes

$500 Billion Stargate AI Project Announcement Raises Funding Questions

$500 Billion Stargate AI Project Announcement Raises Funding Questions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Oracle’s Q4 earnings missed expectations but stock jumped ~11% after new cloud deals

Oracle’s AI Buildout Puts Its Bonds in the Crosshairs as Debt and Lease Commitments Surge

December 16, 2025
Rapamycin: The “Most-Proven-in-Mice” Longevity Drug Still Searching for Human Proof

Rapamycin: The “Most-Proven-in-Mice” Longevity Drug Still Searching for Human Proof

January 19, 2026
Novo Nordisk Q2 2024 Earnings Highlights

Novo Nordisk Forecasts Slower Growth as Weight-Loss Drug Competition Intensifies

February 5, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018